https://www.thebostonexaminer.com/article/905686574-nammu-names-former-seattle-fish-company-ceo-and-nfi-chair-derek-figueroa-as-strategic-advisor The Boston Examiner en PressRelease 2026-04-14T14:11:34+00:00 Nammu Names Former Seattle Fish Company CEO and NFI Chair Derek Figueroa as Strategic Advisor https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832367-nammu-logo-1308x388.png https://www.thebostonexaminer.com/article/905487529-roosites-web-development-recognized-among-best-web-developers-in-boston The Boston Examiner en PressRelease 2026-04-14T13:00:00+00:00 RooSites Web Development Recognized Among Best Web Developers in Boston https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831330-digital-reference-468x263.jpeg https://www.thebostonexaminer.com/article/905530647-newcastle-systems-unveils-latest-innovation-in-mobile-powered-workstations-the-sidekick-industrial-power-station The Boston Examiner en PressRelease 2026-04-14T13:00:00+00:00 Newcastle Systems Unveils Latest Innovation in Mobile-Powered Workstations: The Sidekick Industrial Power Station https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831697-newcastle-logo-440x64.png https://www.thebostonexaminer.com/article/905545605-huddle-house-opens-in-decatur-on-april-14 The Boston Examiner en PressRelease 2026-04-14T12:33:31+00:00 Huddle House Opens in Decatur on April 14 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/22272645-huddle-house-logo-800x800.jpeg https://www.thebostonexaminer.com/article/905668515-victoria-tyler-recognized-by-influential-women-bridges-psychology-coaching-and-creative-arts-to-empower-growth The Boston Examiner en PressRelease 2026-04-14T12:14:11+00:00 Victoria Tyler, Recognized by Influential Women, Bridges Psychology, Coaching, and Creative Arts to Empower Growth https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832285-victoria-tyler-490x556.png https://www.thebostonexaminer.com/article/905494291-the-nssc-releases-statement-following-stephenson-king-jr-s-death-a-triple-systemic-failure The Boston Examiner en PressRelease 2026-04-14T12:00:00+00:00 The NSSC Releases Statement Following Stephenson King Jr.'s Death: A Triple Systemic Failure https://www.thebostonexaminer.com/article/905656338-influential-women-features-nicole-lovitch-behavioral-health-consultant-at-health-management-associates The Boston Examiner en PressRelease 2026-04-14T10:53:09+00:00 Influential Women Features Nicole Lovitch: Behavioral Health Consultant at Health Management Associates https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832245-nicole-lovitch-394x416.png https://www.thebostonexaminer.com/article/904791580-new-documentary-on-microaggression-pioneer-dr-chester-pierce-gains-festival-recognition The Boston Examiner en PressRelease 2026-04-14T10:00:00+00:00 New Documentary on 'Microaggression' Pioneer Dr. Chester Pierce Gains Festival Recognition https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24829942-limitless-the-dr-chester-pier-800x1200.jpeg https://www.thebostonexaminer.com/article/905449556-blancco-and-cambrionix-deliver-industry-first-integration-for-compliant-apple-mac-erasure-and-reimaging-at-scale The Boston Examiner en PressRelease 2026-04-14T10:00:00+00:00 Blancco and Cambrionix Deliver Industry-First Integration for Compliant Apple Mac Erasure and Reimaging at Scale https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831157-compliant-apple-mac-processing-4096x2144.jpeg https://www.thebostonexaminer.com/article/905451997-blancco-cambrionix-liefern-erste-vollst-ndig-integrierte-sichere-skalierbare-l-sung-f-r-mac-l-schung-und-reimaging The Boston Examiner en PressRelease 2026-04-14T10:00:00+00:00 Blancco & Cambrionix liefern erste vollständig integrierte, sichere , skalierbare Lösung für Mac‑Löschung und Reimaging https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831173-de-compliant-apple-mac-processi-4096x2144.jpeg https://www.thebostonexaminer.com/article/905453711-blancco-et-cambrionix-permettent-l-effacement-s-curis-et-la-remise-neuf-des-mac-d-apple-grande-chelle The Boston Examiner en PressRelease 2026-04-14T10:00:00+00:00 Blancco et Cambrionix permettent l'effacement sécurisé et la remise à neuf des Mac d'Apple à grande échelle. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831183-fr-blancco-collab-image-4096x2144.jpeg https://www.thebostonexaminer.com/article/905639051-what-drives-wuxi-apptec-s-25-year-compliance-record-and-why-does-it-matter-for-global-partnerships The Boston Examiner en PressRelease 2026-04-14T09:10:29+00:00 What Drives WuXi AppTec’s 25-Year Compliance Record, and Why Does It Matter for Global Partnerships? https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24832182-a-global-company-operating-in-a-1920x1080.jpeg https://www.thebostonexaminer.com/article/905697961-gordon-brothers-provides-strategic-advisory-175m-integrated-asset-based-facility-featuring-a-rilo-to-support-phillips-pet-food-s-acquisition-of The Boston Examiner en PressRelease 2026-04-14T13:52:45+00:00 Gordon Brothers Provides Strategic Advisory & $175M Integrated Asset Based Facility Featuring a RILO to Support Phillips Pet Food’s Acquisition of Central Pet https://ml.globenewswire.com/media/OGZlZTM2ODgtYmE3ZS00NjQwLWE0OTgtZjZlY2IwYjY4MGQ1LTExMTAxODYtMjAyNi0wNC0xNC1lbg==/tiny/Gordon-Brothers.png https://www.thebostonexaminer.com/article/905685615-progress-software-expands-ai-and-workforce-operations-in-india-with-new-bengaluru-innovation-hub The Boston Examiner en PressRelease 2026-04-14T13:00:00+00:00 Progress Software Expands AI and Workforce Operations in India with New Bengaluru Innovation Hub https://ml.globenewswire.com/media/2a4a917f-af24-458f-b64e-25e5e5cc6c26/small/progress-logo-jpg.jpg https://www.thebostonexaminer.com/article/905686335-salary-com-s-2026-pay-practices-report-finds-hr-pros-believe-pay-is-fair-but-are-not-confident-employees-agree The Boston Examiner en PressRelease 2026-04-14T13:00:00+00:00 Salary.com's 2026 Pay Practices Report Finds HR Pros Believe Pay is Fair But are not Confident Employees Agree https://ml.globenewswire.com/media/YzM3ZTQyZTItOTczZS00YzA5LWFlYzAtMGNhYTI5OTQwOGUxLTEzMTk0NDQtMjAyNi0wNC0xNC1lbg==/tiny/Salary-com.png https://www.thebostonexaminer.com/article/905686904-healthedge-partners-with-ellipsis-health-to-scale-care-management-through-ai-powered-virtual-nursing The Boston Examiner en PressRelease 2026-04-14T13:00:00+00:00 HealthEdge® Partners with Ellipsis Health to Scale Care Management Through AI-Powered Virtual Nursing https://ml.globenewswire.com/media/18d2dfaf-8f95-4f15-99e6-ae8282b42123/small/healthedge-logo-jpg.jpg https://www.thebostonexaminer.com/article/905686914-global-legal-expert-to-unpack-the-geopolitics-of-ai-during-live-online-event-on-april-21 The Boston Examiner en PressRelease 2026-04-14T13:00:00+00:00 Global Legal Expert to Unpack the Geopolitics of AI During Live Online Event on April 21 https://ml.globenewswire.com/media/448470d8-d31c-42b2-81f4-a0a5635707e7/small/ccc-logo-full-color-transparent-background-rgb-digital-use-o.png https://www.thebostonexaminer.com/article/905684517-aware-finds-98-of-organizations-signal-urgent-need-for-biometric-orchestration-as-ai-driven-fraud-surges The Boston Examiner en PressRelease 2026-04-14T12:30:00+00:00 Aware Finds 98% of Organizations Signal Urgent Need for Biometric Orchestration as AI-Driven Fraud Surges https://ml.globenewswire.com/media/a04f465c-3b1c-4f2a-a547-3fcb543ddaa2/small/aware-logo-for-press-releases-jpg.jpg https://www.thebostonexaminer.com/article/905685985-laudio-releases-second-edition-of-award-winning-book-for-frontline-healthcare-leaders-leader-inspired-work The Boston Examiner en PressRelease 2026-04-14T12:30:00+00:00 Laudio Releases Second Edition of Award-Winning Book for Frontline Healthcare Leaders, “Leader Inspired Work” https://ml.globenewswire.com/media/80902464-ce62-4b9b-8b77-23328b91d046/medium/leader-inspired-work.jpg https://www.thebostonexaminer.com/article/905670526-maestra-io-hits-2x-q1-2026-arr-as-e-commerce-demand-grows-for-all-in-one-marketing-with-forward-deployed-execution The Boston Examiner en PressRelease 2026-04-14T12:02:00+00:00 Maestra.io Hits 2x Q1 2026 ARR as E-Commerce Demand Grows for All-in-One Marketing with Forward-Deployed Execution https://ml.globenewswire.com/media/MzYyNTkyYmItMjYwOS00MmQxLWJlZTItOTc4OTUyZTIxYzY1LTUwMDE1MjgzNC0yMDI2LTA0LTE0LWVu/tiny/Maestra.png https://www.thebostonexaminer.com/article/905671239-powered-by-builders-and-industry-leaders-vistashares-surpasses-1-billion-in-assets The Boston Examiner en PressRelease 2026-04-14T12:00:00+00:00 Powered by Builders and Industry Leaders, VistaShares Surpasses $1 Billion in Assets  https://ml.globenewswire.com/media/7364a55a-8e5d-42dd-9ac2-11e625fbb659/small/picture1-jpg.jpg https://www.thebostonexaminer.com/article/905672627-corbus-pharmaceuticals-announces-last-patient-first-visit-in-canyon-1-study-of-crb-913-for-the-treatment-for-obesity The Boston Examiner en PressRelease 2026-04-14T12:00:00+00:00 Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity https://ml.globenewswire.com/media/459d6fb1-b336-4d47-8aa1-f9198bda891d/small/corbus-logo-jpg.jpg https://www.thebostonexaminer.com/article/905674478-ehra-2026-studies-reveal-why-false-positives-persist-in-ai-equipped-implantable-cardiac-monitors The Boston Examiner en PressRelease 2026-04-14T12:00:00+00:00 EHRA 2026 Studies Reveal Why False Positives Persist in AI-Equipped Implantable Cardiac Monitors https://ml.globenewswire.com/media/9b201748-0dfa-4e94-92d7-9d552b344904/medium/false-positive-rate-of-modern-icms-according-to-guideline-de.png https://www.thebostonexaminer.com/article/905671585-praxis-precision-medicines-announces-fda-acceptance-of-new-drug-application-for-ulixacaltamide-hcl-in-patients-with-essential-tremor The Boston Examiner en PressRelease 2026-04-14T11:30:00+00:00 Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.thebostonexaminer.com/article/905547663-new-book-dollars-to-doughnuts-imagining-a-sustainable-future-launches-april-15-2026 The Boston Examiner en PressRelease 2026-04-13T23:24:41+00:00 New Book, Dollars to Doughnuts: Imagining a Sustainable Future, Launches April 15, 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831685-book-cover-dollars-to-doughnuts-1767x2650.jpeg https://www.thebostonexaminer.com/article/905673210-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 The Boston Examiner en PressRelease 2026-04-14T11:00:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.thebostonexaminer.com/article/905504840-super-brush-to-exhibit-at-mro-americas-2026-in-orlando-showcasing-precision-foam-swab-solutions-for-aviation-maintenance The Boston Examiner en PressRelease 2026-04-13T16:37:57+00:00 Super Brush to Exhibit at MRO Americas 2026 in Orlando Showcasing Precision Foam Swab Solutions for Aviation Maintenance https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831532-we-re-exhibiting-at-mro-america-1536x527.jpeg https://www.thebostonexaminer.com/article/905493565-choate-expands-fund-formation-and-investment-management-practice-with-former-lowenstein-partner-jonathan-danziger The Boston Examiner en PressRelease 2026-04-13T15:05:20+00:00 Choate Expands Fund Formation and Investment Management Practice with Former Lowenstein Partner Jonathan Danziger https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/15938189-choate-logo-1962x313.png https://www.thebostonexaminer.com/article/904937665-seacoast-ai-uses-leverage-s-sovereign-ai-to-put-its-data-to-work The Boston Examiner en PressRelease 2026-04-13T14:38:00+00:00 Seacoast AI Uses Leverage’s Sovereign AI to Put Its Data to Work https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830795-seacoast-ai-1920x1080.png https://www.thebostonexaminer.com/article/905025517-town-of-millbury-partners-with-planetbids-to-modernize-and-streamline-procurement-processes The Boston Examiner en PressRelease 2026-04-13T13:00:00+00:00 Town of Millbury Partners with PlanetBids to Modernize and Streamline Procurement Processes https://www.thebostonexaminer.com/article/901452671-imex-cargo-expands-workforce-development-strategy-to-power-digital-freight-infrastructure-through-plug-in-freight-ops The Boston Examiner en PressRelease 2026-04-13T12:00:00+00:00 ‘ImEx Cargo Expands Workforce Development Strategy to Power Digital Freight Infrastructure Through Plug-In Freight Ops™’ https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24814451-imex-cargo-academy-preparing-ta-500x500.png https://www.thebostonexaminer.com/article/905465559-influential-women-profiles-kim-shivers-championing-people-first-leadership-through-value-your-people-consulting The Boston Examiner en PressRelease 2026-04-13T11:02:34+00:00 Influential Women Profiles Kim Shivers: Championing People-First Leadership Through Value Your People Consulting https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24831229-kim-shivers-394x404.png https://www.thebostonexaminer.com/article/905557669-automated-retail-technologies-and-evolvending-partner-to-expand-24-7-dining-in-u-s-airports The Boston Examiner en PressRelease 2026-04-13T23:01:12+00:00 Automated Retail Technologies and Evolvending Partner to Expand 24/7 Dining in U.S. Airports https://ml.globenewswire.com/media/d0fba344-8be1-4351-ac50-f88f27e435b4/medium/cover-image.jpg https://www.thebostonexaminer.com/article/905389327-boston-pads-database-surpasses-300-000-units-expanding-footprint-beyond-greater-boston The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 Boston Pads Database Surpasses 300,000 Units, Expanding Footprint Beyond Greater Boston https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24581669-boston-pads-320x320.jpeg https://www.thebostonexaminer.com/article/905549936-high-income-securities-fund-announces-monthly-distributions-for-second-quarter-of-2026 The Boston Examiner en PressRelease 2026-04-13T22:28:20+00:00 High Income Securities Fund Announces Monthly Distributions For Second Quarter of 2026 https://ml.globenewswire.com/media/ZjFmZWVjYWMtNmI4NC00YzQyLWJmMmQtYTlmZjVmZWVmODE4LTEzMjE3MDYtMjAyNi0wNC0xMy1lbg==/tiny/High-Income-Securities-Fund.png https://www.thebostonexaminer.com/article/905542368-spyre-therapeutics-announces-proposed-public-offering-of-its-common-stock The Boston Examiner en PressRelease 2026-04-13T20:46:48+00:00 Spyre Therapeutics Announces Proposed Public Offering of its Common Stock https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.thebostonexaminer.com/article/905535390-celldex-to-present-at-upcoming-investor-conference The Boston Examiner en PressRelease 2026-04-13T20:01:00+00:00 Celldex to Present at Upcoming Investor Conference https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png https://www.thebostonexaminer.com/article/905402725-sunway-medical-centre-penang-recognized-as-emerging-tertiary-medical-hub-malaysia-by-global-brand-frontier-awards-2025 The Boston Examiner en PressRelease 2026-04-13T05:38:09+00:00 Sunway Medical Centre Penang Recognized as Emerging Tertiary Medical Hub – Malaysia by Global Brand Frontier Awards 2025 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24830973-sunway-medical-main-3750x1969.jpeg https://www.thebostonexaminer.com/article/905511446-dermatology-devices-market-to-reach-25-6-billion-by-2030-driven-by-rising-skin-cancer-incidence-and-aesthetic-demand The Boston Examiner en PressRelease 2026-04-13T17:21:11+00:00 Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.thebostonexaminer.com/article/905496045-sentinel-group-strengthens-growth-strategy-with-two-senior-leadership-appointments The Boston Examiner en PressRelease 2026-04-13T15:14:12+00:00 Sentinel Group Strengthens Growth Strategy with Two Senior Leadership Appointments https://ml.globenewswire.com/media/aacb4399-9cc2-42d0-b1f0-675cc62d7d92/medium/headshots.png https://www.thebostonexaminer.com/article/905483267-merlin-further-expands-executive-team-appointing-mark-brunner-as-chief-revenue-officer The Boston Examiner en PressRelease 2026-04-13T13:20:13+00:00 Merlin Further Expands Executive Team Appointing Mark Brunner as Chief Revenue Officer https://ml.globenewswire.com/media/368ea8dd-210e-4fb6-9c0c-887bc5643e29/medium/mark-brunner.png https://www.thebostonexaminer.com/article/905478638-microbot-medical-commences-full-market-release-fmr-of-the-liberty-endovascular-robotic-system-in-the-u-s-at-the-society-of-interventional The Boston Examiner en PressRelease 2026-04-13T12:30:00+00:00 Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://www.thebostonexaminer.com/article/905474861-mks-inc-announces-first-quarter-2026-earnings-conference-call The Boston Examiner en PressRelease 2026-04-13T12:00:00+00:00 MKS Inc. Announces First Quarter 2026 Earnings Conference Call https://ml.globenewswire.com/media/a922cdbe-9964-4f52-86d5-ff5e42639bb0/small/mks-color-logo-jpg.jpg https://www.thebostonexaminer.com/article/905475009-praxis-to-showcase-essential3-the-first-positive-phase-3-program-in-essential-tremor-at-aan-2026 The Boston Examiner en PressRelease 2026-04-13T12:00:00+00:00 Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026 https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg https://www.thebostonexaminer.com/article/905475064-akebia-therapeutics-announces-first-participants-dosed-in-phase-1-clinical-trial-of-akb-9090 The Boston Examiner en PressRelease 2026-04-13T12:00:00+00:00 Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090 https://ml.globenewswire.com/media/c7f3708e-3328-4668-95c6-e7646efd653a/small/akebia-logo-fullcolor-rgb-png.png https://www.thebostonexaminer.com/article/905466972-kymera-therapeutics-announces-u-s-fda-fast-track-designation-for-kt-621-a-first-in-class-oral-stat6-degrader-for-the-treatment-of-moderate-to The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 Kymera Therapeutics Announces U.S. FDA Fast Track Designation for KT-621, a First-in-Class, Oral STAT6 Degrader for the Treatment of Moderate to Severe Asthma https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.thebostonexaminer.com/article/905466973-spyre-announces-potential-best-in-class-spy001-part-a-induction-results-from-skyline-trial-in-moderate-to-severe-ulcerative-colitis-patients The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients https://ml.globenewswire.com/media/bc26a912-b583-43c6-8423-55a4ba2bf4bd/small/spyre-logo-horizontal-full-color-rgb-583px-300ppi-jpg.jpg https://www.thebostonexaminer.com/article/905466986-ocular-therapeutix-announces-additional-positive-week-52-data-from-landmark-sol-1-phase-3-trial-of-axpaxli-in-wet-amd The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.thebostonexaminer.com/article/905467081-imagenebio-announces-30-million-private-placement The Boston Examiner en PressRelease 2026-04-13T11:00:00+00:00 ImageneBio Announces $30 Million Private Placement https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg